Telmisartan

Routes
Oral (PO)
Half-Life (t½)
PO: 24h
Formula
C33H30N4O2
Molecular Weight
514.62 g/mol
PubChem CID
65999
Aliases
Micardis

Pharmacological Mechanism

AT1 receptor blocker + partial PPAR-γ agonist — unique among ARBs in modest insulin-sensitizing activity. Long half-life supports once-daily dosing. Research interest as a longevity / metabolic compound goes beyond standard ARB use.

Half-Life & Elimination Curve (PO: 24h)

100%50%25%12.5%0%0h0×t½24h1×t½48h2×t½3d3×t½4d4×t½5d5×t½0×t½ (0h): 100% remaining (~31.7 µg/L)1×t½ (24h): 50% remaining (~15.8 µg/L)2×t½ (48h): 25% remaining (~7.92 µg/L)3×t½ (3d): 12.5% remaining (~3.96 µg/L)4×t½ (4d): 6.3% remaining (~1.98 µg/L)5×t½ (5d): 3.1% remaining (~0.991 µg/L)
Plasma (PO)t½ Decay (24h)Effect Site (ke0)
  • 0×t½0h100% (31.7 µg/L)
  • 1×t½24h50% (15.8 µg/L)
  • 2×t½48h25% (7.92 µg/L)
  • 3×t½3d12.5% (3.96 µg/L)
  • 4×t½4d6.3% (1.98 µg/L)
  • 5×t½5d3.1% (0.991 µg/L)
Elimination t½24h (PO)
Rate Constant (ke)0.0289 h⁻¹
Time to Peak (Tmax)2.83h
Est. Peak (Cmax)31.7 µg/L
Clearance (CL)14.4 L/h
97% Washout (5×t½)5d

Dosing Guidelines

Pharmacokinetic Parameters

Receptor Binding & Occupancy

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References